PCAS has 750m3 capacity for producing active pharmaceutical ingredients and advanced intermediates. PCAS, a full range of services for the Pharmaceutical Industry, has: - 5 R&D Units for synthesis- 125 Scientists. - 4 plants ISO 9001 (400m3) for chemical intermediates. - 4 plants cGMP (350m3) for APIs production. - PCAS, areas of special expertise: PCAS has 20m3 of cGMP capacity available for cryogenic reactions (-90C), combined with organometallic reagents that support part of our special expertise in chiral synthesis. PLGA polymers for sustained release formulation. Acrolein and bromine chemistry. Thiophene and phosphorous derivatives. 4 and 7 Azaindoles derivatives. Regulatory Affairs Expertise. PCAS, other activities: Aroma chemicals Organic intermediates Industrial speciality chemicals Fine mineral chemicals Photochemicals & electronics.
